Overview

Teneligliptin and Atorvastatin DDI Study

Status:
Completed

Trial end date:
2019-02-25

Target enrollment:

Participant gender:

Summary

A randomized, open-label, cross-over, multiple dosing study to evaluate drug-drug interaction between Teneligliptin and Atorvastatin in healthy male adults

Phase:

Phase 1

Details

Lead Sponsor:

Handok Inc.
Handok Pharmaceuticals Co., Ltd.

Treatments:

Atorvastatin
Atorvastatin Calcium